WASHINGTON: United States Food and Drug Administration encouraged hospitals not to use a leading brand of drug pump over hacking fears.
Hospira, which made the Symbiq Infusion System pump had already discontinued the product for business reasons. The devices were previously revealed to be hackable by an independent researcher.
The FDA asked hospitals to switch to alternative infusion systems as soon as possible.
